BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8381695)

  • 1. Cytomegalovirus infection presenting as polyarticular arthritis following autologous BMT.
    Burns LJ; Gingrich RD
    Bone Marrow Transplant; 1993 Jan; 11(1):77-9. PubMed ID: 8381695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of severe cytomegalovirus infection with ganciclovir and high-dose intravenous immunoglobulin in patients with allogeneic bone marrow transplants. A pilot study.
    Lehn P; Quessar A; Devergie A; Esperou-Bourdeau H; Traineau R; Trédaniel J; Benbunan M; Bussel A; Jolivet I; Mazeron MC
    Nouv Rev Fr Hematol (1978); 1990; 32(1):17-20. PubMed ID: 2161510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.
    Canpolat C; Culbert S; Gardner M; Whimbey E; Tarrand J; Chan KW
    Bone Marrow Transplant; 1996 Apr; 17(4):589-93. PubMed ID: 8722360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid detection of CMV reactivation after BMT by CMV-IEA expression in granulocytes.
    Boland GJ; Vlieger A; de Gast GC; Zwaan FE; Verdonck LF; de Weger RA; Jiwa NM
    Bone Marrow Transplant; 1991; 7 Suppl 2():42. PubMed ID: 1652328
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytomegalovirus infection in the bone marrow transplant recipient.
    Zaia JA; Forman SJ
    Infect Dis Clin North Am; 1995 Dec; 9(4):879-900. PubMed ID: 8747771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
    Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
    Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preemptive ganciclovir administration based solely on asymptomatic pulmonary cytomegalovirus infection in allogeneic bone marrow transplant recipients: long-term follow-up.
    Zaia JA; Schmidt GM; Chao NJ; Rizk NW; Nademanee AP; Niland JC; Horak DA; Lee J; Gallez-Hawkins G; Kusnierz-Glaz CR
    Biol Blood Marrow Transplant; 1995 Dec; 1(2):88-93. PubMed ID: 9118297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid detection cytomegalovirus pneumonia in recipients of bone marrow transplant: evaluation and comparison of five survey methods for bronchoalveolar lavage fluid.
    Goto H; Yuasa K; Sakamaki H; Nakata K; Komuro I; Iguchi M; Okamura T; Ieki R; Tanikawa S; Akiyama H; Onozawa Y; Mochida Y
    Bone Marrow Transplant; 1996 May; 17(5):855-60. PubMed ID: 8733709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should all CMV infections after bone marrow transplantation be treated?
    Jouet JP; Draoui A; Facon T; Noel-Walter MP; Wattre P; Fenaux P; Dupriez B; Morel P; Bauters F
    Bone Marrow Transplant; 1991; 7 Suppl 2():47. PubMed ID: 1652333
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful treatment of cytomegalovirus pneumonitis with ganciclovir and high-dose intravenous immunoglobulin in a bone marrow transplant recipient.
    Chow JM; Lin MT; Chen YC; Chang SC; Su IJ; Tang JL
    J Formos Med Assoc; 1992 Oct; 91(10):996-1000. PubMed ID: 1362680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised trial comparing cytomegalovirus antigenemia assay vs screening bronchoscopy for the early detection and prevention of disease in allogeneic bone marrow and peripheral blood stem cell transplant recipients.
    Humar A; Lipton J; Welsh S; Moussa G; Messner H; Mazzulli T
    Bone Marrow Transplant; 2001 Sep; 28(5):485-90. PubMed ID: 11593322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients.
    Ljungman P; Loré K; Aschan J; Klaesson S; Lewensohn-Fuchs I; Lönnqvist B; Ringdén O; Winiarski J; Ehrnst A
    Bone Marrow Transplant; 1996 Apr; 17(4):583-7. PubMed ID: 8722359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CMV prophylaxis in allogeneic BMT with ganciclovir and CMV immune globulin.
    Patton WN; Carter C; Bienz N; Lamb T; Boughton BJ; Franklin IM
    Bone Marrow Transplant; 1991; 7 Suppl 2():44. PubMed ID: 1652330
    [No Abstract]   [Full Text] [Related]  

  • 14. Ganciclovir and standard high-dose immunoglobulins for the treatment of cytomegalovirus interstitial pneumonia in a bone marrow recipient.
    Iori AP; Gentile G; Petasecca Donati P; Arcese W; Martino P; Mandelli F
    Haematologica; 1990; 75(4):394-6. PubMed ID: 2177441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus viremia, viruria and disease after autologous peripheral blood stem cell transplantation: no need for surveillance.
    Bilgrami S; Aslanzadeh J; Feingold JM; Bona RD; Clive J; Dorsky D; Edwards RL; Tutschka PJ
    Bone Marrow Transplant; 1999 Jul; 24(1):69-73. PubMed ID: 10435738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection.
    Einsele H; Hebart H; Kauffmann-Schneider C; Sinzger C; Jahn G; Bader P; Klingebiel T; Dietz K; Löffler J; Bokemeyer C; Müller CA; Kanz L
    Bone Marrow Transplant; 2000 Apr; 25(7):757-63. PubMed ID: 10745262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cytomegalovirus antigenemia and shell vial culture in allogeneic marrow transplantation recipients receiving ganciclovir prophylaxis.
    Nicholson VA; Whimbey E; Champlin R; Abi-Said D; Przepiorka D; Tarrand J; Chan K; Bodey GP; Goodrich JM
    Bone Marrow Transplant; 1997 Jan; 19(1):37-41. PubMed ID: 9012929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-emptive ganciclovir treatment can play a role in restoration of hematopoiesis after allogeneic bone marrow transplantation.
    Choi JH; Kim DW; Cho SG; Yoo JH; Jeong DC; Han CW; Shin WS; Min WS; Kim HK; Kim CC; Kim DJ
    Bone Marrow Transplant; 1997 Jan; 19(2):187-90. PubMed ID: 9116619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus infections in transplant patients.
    Ljungman P
    Scand J Infect Dis Suppl; 1996; 100():59-63. PubMed ID: 8860355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sputum induction as an aid to diagnosis of active cytomegalovirus infection following bone marrow transplantation.
    Foot AB; Caul EO; Roome AP; Cornish JM; Catterall JR
    Bone Marrow Transplant; 1990 Apr; 5(4):283-4. PubMed ID: 2159820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.